National Institute of Allergy and Infectious Diseases
The first-in-human, Phase 1 trial will assess the safety and protection of a universal influenza vaccine
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.